Home › Markets › Industrials › MOS

Mosaic Company (The) (MOS)

MOS trades on NYSE in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$19.18
+1.75% on the day
Market cap
$6.1B
Mid cap
Revenue · 2025
$12.1B
+8.4% on 2024
Net income · 2025
$541.0M
4.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerMOS on NYSE
SectorIndustrials
IndustryAgricultural Chemicals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001285785
SEC industry codeAgricultural Chemicals

Financials · 2025

LineValue
Revenue$12.1B
Net income$541.0M
Operating income$821.5M
Net margin4.5%
Operating margin6.8%
Revenue growth+8.4%
Cash$276.6M
Total assets$24.5B
P/E (computed)11.3×
P/S (computed)0.5×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-08-12
Latest annual report10-K/A2026-03-17
Latest quarterly / interim10-Q2026-08-05
Latest current report8-K2026-09-25
Latest proxyDEF 14A2026-04-16

Source: SEC EDGAR submissions feed, 1,005 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.8%
1 month-25.3%
3 months-15.6%
Year to date-21.1%
1 year-38.7%
From 52-week high-39.4%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Agricultural Chemicals

TickerCompanyPriceDayMarket cap
ICLICL Group Ltd.$4.98+0.81%$6.4B
SMGScotts Miracle-Gro Company (The)$50.10+0.32%$2.9B
CFCF Industries Holdings Inc.$117.25+2.33%$17.7B
UANCVR Partners LP Common Units representing Limited Partner Interests$126.21+0.57%$1.3B
NTRNutrien Ltd. Common Shares$69.68+2.47%$33.6B
CBUSCibus Inc.$1.41-4.73%$107.8M
AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.33-5.67%$39.2M
BIOXBioceres Crop Solutions Corp.$0.3250-1.81%$20.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier